G47 Delta-results available on 17thNovember

[Harvey]

Hello Al,

please look at this (and if the results will be positive, try to make pressure, so the treatment can be available as soon as possible😊)

https://www.cancertreatmentsresearch...todo-in-japan/

[musella]

It does look interesting. Remind us on that day.

[Harvey]

Hello Al, here a reminder (better late then never).
As I understood, there were physicians from US present as well (since it was a joint US-Japan summit).

I don’t understand how come this therapy didn’t get / isn’t recieving any (media) attention in the US/EU.

Please comment.

Thanks,
Harvey

[Harvey]

Here’s the link to the summit website..I still can’t find something that I can communicate to NOs/Surgeons.

thanks!
harvey

[Harvey]

https://cancer-zero.com/

[Harvey]

It seems like the therapy from prof. Todo was an central element of the Summit:

https://cancer-zero.com/summit005/moonshot.html

[musella]

It sounds good. What is the status of the clinical trials?

[Harvey]

They are finished, both of them..apparently they presented full results ( not only percentage of 1-year survivors) yesterday but I can’t find them.

Heres the trial:

https://upload.umin.ac.jp/cgi-open-b...598&language=E

[Harvey]

I don’t know what is the status of approval protocol at Japanese Agency.

Heres a Short summary (but nothing specific) of the summit:

https://ameblo.jp/kakutasuyamanoyani...546326909.html

[Harvey]

https://academic.oup.com/neuro-oncol...dFrom=fulltext

[Harvey]

Finally, an abstract of the treatment with g47 delta Virus (the trial was terminated early due to success!!!)


https://academic.oup.com/neuro-oncol...dFrom=fulltext

[musella]

Those are quite remarkable. I just sent it out in the news blast. I am at SNO and see what they think about it here.
On the flight here I sat next to a researcher working on a new type of treatment - they will do first in man studies in Febuary.. I chewed her ear off for 6 hours Will tell more about it when the trial starts up

[Harvey]

Virus (G47 DELTA / commercial Name: DS-1647) will be brought to the market trough Pharmacompany Daiichi Sankyo.

Daiichi Sankyo is positioned strongly both in Europe and US.
A good thing!

Here the presentations:

https://www.daiichisankyo.co.jp/ir/c...7%E6%96%99.pdf

https://www.daiichisankyo.co.jp/ir/calendar/files/005446/2019%E5%B9%B4%E

[Harvey]

Here the summaried interview with prof. Todo held at SNO 2019


https://www.practiceupdate.com/c/928...0&lid=10332481v

[musella]

Looks great! the trial was stopped early because it worked too good! It is a small trial but still impressive. Available in Japan only right now but hoefully will be approved in Japan soon